HomeCompareSNCE vs EQR

SNCE vs EQR: Dividend Comparison 2026

SNCE yields 34.78% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SNCE wins by $126.0K in total portfolio value
10 years
SNCE
SNCE
● Live price
34.78%
Share price
$5.75
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$173.8K
Annual income
$26,108.19
Full SNCE calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — SNCE vs EQR

📍 SNCE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSNCEEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SNCE + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SNCE pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SNCE
Annual income on $10K today (after 15% tax)
$2,956.52/yr
After 10yr DRIP, annual income (after tax)
$22,191.96/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, SNCE beats the other by $17,537.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SNCE + EQR for your $10,000?

SNCE: 50%EQR: 50%
100% EQR50/50100% SNCE
Portfolio after 10yr
$110.8K
Annual income
$15,791.90/yr
Blended yield
14.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

SNCE
Analyst Ratings
1
Buy
3
Hold
Consensus: Hold
Altman Z
-3.2
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SNCE buys
0
EQR buys
0
No recent congressional trades found for SNCE or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSNCEEQR
Forward yield34.78%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$173.8K$47.8K
Annual income after 10y$26,108.19$5,475.61
Total dividends collected$125.1K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldHold

Year-by-year: SNCE vs EQR ($10,000, DRIP)

YearSNCE PortfolioSNCE Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$14,178$3,478.26$11,380$679.82+$2.8KSNCE
2$19,780$4,608.94$13,014$837.25+$6.8KSNCE
3$27,173$6,009.16$14,961$1,036.20+$12.2KSNCE
4$36,791$7,715.34$17,297$1,289.22+$19.5KSNCE
5$49,129$9,762.64$20,121$1,613.15+$29.0KSNCE
6$64,752$12,183.73$23,561$2,030.84+$41.2KSNCE
7$84,292$15,007.57$27,783$2,573.54+$56.5KSNCE
8$108,451$18,258.34$33,013$3,284.39+$75.4KSNCE
9$137,997$21,954.52$39,547$4,223.51+$98.5KSNCE
10$173,765$26,108.19$47,791$5,475.61+$126.0KSNCE

SNCE vs EQR: Complete Analysis 2026

SNCEStock

Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Its platform enables modern and digital approaches to clinical research by bringing together all parties, including the patient and trial investigators, nurses, coordinators, and sponsors to power workflows, centralize evidence generation, and harmonize data. Its platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating agile clinical trials; and extensive configuration to support virtually any phase of clinical study and any indication. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina.

Full SNCE Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this SNCE vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SNCE vs SCHDSNCE vs JEPISNCE vs OSNCE vs KOSNCE vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.